Astellas Established Markets-Commercial (EST-C) operates in 36 countries, speaking 23 main languages, and is a regional business of Tokyo-based Astellas Pharma Inc.
The EST-C region headquarters are based in the UK, and support the affiliate teams across Europe, Israel and Canada, working in collaboration with the Manufacturing and Medical & Development sites in Ireland and the Netherlands.
We are determined to answer the unmet medical needs of people around the world. Building on our heritage in a diverse range of therapeutic areas, we continue to invest in research and development to support new medicines and technologies.
The passion of our 3,500+ people throughout the region help us to continue to make a difference to the lives of patients and our values of patient focus, ownership, results, openness and integrity guide us in everything that we do.
MAT-UK-NON-2022-00190 Date of prep: October 2022